Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 4/2013

01-08-2013 | Research Article

Analysis of the methylation patterns of the p16 INK4A , p15 INK4B , and APC genes in gastric adenocarcinoma patients from a Brazilian population

Authors: Bárbara do Nascimento Borges, Rommel Mario Rodriguez Burbano, Maria Lúcia Harada

Published in: Tumor Biology | Issue 4/2013

Login to get access

Abstract

Gastric cancer is a major public health problem in Pará state, where studies suggest complex genetic and epigenetic profiles of the population, indicating the need for the identification of molecular markers for this tumor type. In the present study, the methylation patterns of three genes [p16 INK4A , p15 INK4B , and adenomatous polyposis coli (APC)] were assessed in patients with gastric adenocarcinoma from Pará state in order to identify possible molecular markers of gastric carcinogenesis. DNA samples from tumoral and non-tumoral gastric tissues were modified with sodium bisulfite. A fragment of the promoter region of each gene was amplified and sequenced, and samples with more than 20 % of methylated CpG sites were considered hypermethylated. The correlation between the methylation pattern of the selected genes and the MTHFR C677T polymorphism, as well as the relationship between APC and CDH1 methylation, were evaluated. The results suggest that APC hypermethylation is an age-specific marker of gastric carcinogenesis, and the concordance of this event with CDH1 hypermethylation suggests that the Wnt pathway has an important role in gastric carcinogenesis. While the hypermethylation pattern of p15 INK4B seems to be an earlier event in this type of tumor, the hypomethylated status of this gene seems to be correlated to the C677T MTHFR TT genotype. On the other hand, the observed pattern of p16 INK4A hypermethylation suggests that this event is a good marker for the gastric cancer pathway in the Pará state population.
Literature
1.
Instituto Nacional do Câncer (INCA). Estimativa 2012. Incidência de Câncer no Brasil. Instituto Nacional de Câncer José Alencar Gomes da Silva/Ministério da Saúde. Rio de Janeiro: Coordenação Geral de Ações Estratégicas, Coordenação de Prevenção e Vigilância; 2011.
2.
Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr. 2012;3:21–38.PubMedCrossRef
3.
Auclair G, Weber M. Mechanisms of DNA methylation and demethylation in mammals. Biochimie. 2012;94:2202–11.PubMedCrossRef
4.
Lewin J, Schmitt AO, Adorján P, Hildmann T, Piepenbrock C. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics. 2004;20:3005–12.PubMedCrossRef
5.
Ushijima T, Okochi-Takada E. Aberrant methylations in cancer cells: where do they come from? Cancer Sci. 2005;96:206–11.PubMedCrossRef
6.
Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol. 2007;211:287–95.PubMedCrossRef
7.
8.
Katoh M, Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res. 2007;13:4042–5.PubMedCrossRef
9.
MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9–26.PubMedCrossRef
10.
Qin Y, Liu JY, Li B, Sun ZL, Sun ZF. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis. World J Gastroenterol. 2004;10:1276–80.PubMed
11.
Tadokoro H, Shigihara T, Ikeda T, Takase M, Suyama M. Two distinct pathways of p16 gene inactivation in gallbladder cancer. World J Gastroenterol. 2007;13:6396–403.PubMedCrossRef
12.
Chim CS, Fung TK, Wong KF, Lau JS, Law M, Liang R. Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients. J Clin Pathol. 2006;59:921–6.PubMedCrossRef
13.
Deligezer U, Erten N, Akisik EE, Dalay N. Methylation of the INK4A/ARF locus in blood mononuclear cells. Ann Hematol. 2006;85:102–7.PubMedCrossRef
14.
Ota N, Kawakami K, Okuda T, Takehara A, Hiranuma C, Oyama K, et al. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis. Anticancer Res. 2006;26:3729–32.PubMed
15.
Braggio E, Maiolino A, Gouveia ME, Magalhães R, Souto Filho JT, Garnica M, et al. Methylation status of nine tumor suppressor genes in multiple myeloma. Int J Hematol. 2010;91:87–96.PubMedCrossRef
16.
Iyer P, Zekri AR, Hung CW, Schiefelbein E, Ismail K, Hablas A, et al. Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients. Exp Mol Pathol. 2010;88:107–11.PubMedCrossRef
17.
Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand. 1965;64:31–9.PubMed
18.
Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821–6.PubMedCrossRef
19.
Kawamata N, Inagaki N, Mizumura S, Sugimoto KJ, Sakajiri S, Ohyanagi-Hara M, et al. Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders. Eur J Haematol. 2005;74:424–9.PubMedCrossRef
20.
Clément G, Bosman FT, Fontolliet C, Benhattar J. Monoallelic methylation of the APC promoter is altered in normal gastric mucosa associated with neoplastic lesions. Cancer Res. 2004;64:6867–73.PubMedCrossRef
21.
Dobrovic A, Bianco T, Tan LW, Sanders T, Hussey D. Screening for and analysis of methylation differences using methylation-sensitive single-strand conformation analysis. Methods. 2002;27:134–8.PubMedCrossRef
22.
Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. 1999;41:95–8.
23.
Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics. 2005;21:4067–8.PubMedCrossRef
24.
Borges BN, Santos ES, Bastos CEMC, Pinto LC, Anselmo NP, Quaresma JAS, et al. Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from Northern Brazil. Anticancer Res. 2010;30:2225–34.
25.
Morán A, Fernández-Marcelo T, Carro J, De Juan C, Pascua I, Head J, et al. Methylation profiling in non-small cell lung cancer: clinical implications. Int J Oncol. 2012;40:739–46.PubMed
26.
Mirmohammadsadegh A, Marini A, Nambiar S, Hassan M, Tannapfel A, Ruzicka T, et al. Epigenetic silencing of the PTEN gene in melanoma. Cancer Res. 2006;66:6546–52.PubMedCrossRef
27.
Guenin S, Mouallif M, Deplus R, Lampe X, Krusy N, Calonne E, et al. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis. PLoS One. 2012;7:e42704.PubMedCrossRef
28.
Moore LE, Nickerson ML, Brennan P, Toro JR, Jaeger E, Rinsky J, et al. Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors. PLoS Genet. 2011;7:e1002312.PubMedCrossRef
29.
Kawai Y, Sakano S, Suehiro Y, Okada T, Korenaga Y, Hara T, et al. Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma. Ann Oncol. 2010;21:1612–7.PubMedCrossRef
30.
Cheetham S, Tang MJ, Mesak F, Kennecke H, Owen D, Tai IT. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-aza-2′deoxycytidine to increase SPARC expression and improve therapy response. Br J Cancer. 2008;98:1810–9.PubMedCrossRef
31.
Motta FJN. Instabilidade de Microssatélites em Tumores Gástricos na População Paraense. Dissertation. Belém: Universidade Federal do Pará; 2004.
32.
Borges BN, Burbano RR, Harada ML. Survivin -31C/G polymorphism and gastric cancer risk in a Brazilian population. Clin Exp Med. 2011;11:189–93.CrossRef
33.
Neves Filho EHC, Alves MKS, Lima VP, Rabenhorst SHB. MTHFR C677T polymorphism and differential methylation status in gastric cancer: an association with Helicobacter pylori infection. Virchows Arch. 2010;457:627–33.PubMedCrossRef
34.
Ayres M, Ayres Jr M, Ayres DL, Santos AAS. BioEstat. Aplicações estatísticas nas áreas das ciências bio-médicas v. 5.0. Belém: Instituto de Desenvolvimento Sustentável Mamirauá; 2007.
35.
Zhu J, Yao X. Use of DNA methylation for cancer detection and molecular classification. J Biochem Mol Biol. 2007;40:135–41.PubMedCrossRef
36.
Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, Mcclean MD, et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2007;16:108–14.PubMedCrossRef
37.
Model F, Osborn N, Ahlquist D, Gruetzmann R, Molnar B, Sipos F, et al. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease. Mol Cancer Res. 2007;5:153–63.PubMedCrossRef
38.
Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 2000;60:4366–71.PubMed
39.
Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab Invest. 2003;83:519–26.PubMed
40.
Ksiaa F, Ziadi S, Amara K, Korbi S, Trimeche M. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma. Clin Chim Acta. 2009;404:128–33.PubMedCrossRef
41.
42.
43.
Thorstensen L, Lind GE, Løvig T, Diep CB, Meling GI, Rognum TO, et al. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia. 2005;7:99–108.PubMedCrossRef
44.
Beherns J. The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem Soc Trans. 2005;33:672–5.CrossRef
45.
Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007;19:150–8.PubMedCrossRef
46.
Cheng XX, Wang ZC, Chen XY, Sun Y, Kong QY, Liu J, et al. Frequent loss of membranous E-cadherin in gastric cancers: a cross-talk with Wnt in determining the fate of beta-catenin. Clin Exp Metastasis. 2005;22:85–93.PubMedCrossRef
47.
Oshima H, Oguma K, Du YC, Oshima M. Prostaglandin E2, Wnt, and BMP in gastric tumor mouse models. Cancer Sci. 2009;100:1779–85.PubMedCrossRef
48.
Sarrió D, Moreno-Bueno G, Hardisson D, Sánchez-Estévez C, Guo M, Herman JG, et al. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer. 2003;106:208–15.PubMedCrossRef
49.
Tang M, Torres-Lanzas J, Lopez-Rios F, Esteller M, Sanchez-Cespedes M. Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lung. Int J Cancer. 2006;119:2603–6.PubMedCrossRef
50.
Leung WK, Yu J, Ng EK, To KF, Ma PK, Lee TL, et al. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer. 2011;91:2294–301.CrossRef
51.
Kolesnikova EY, Tamkovich SN, Bryzgunova OE, Shelestyuk PI, Permyakova VI, Vlassov VV, et al. Circulating DNA in the blood of gastric cancer patients. Ann N Y Acad Sci. 2008;1137:226–31.PubMedCrossRef
52.
Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 1995;55:4531–5.PubMed
53.
Kanyama Y, Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S, et al. Detection of p16 promoter hypermethylation in serum of gastric cancer patients. Cancer Sci. 2003;94:418–20.PubMedCrossRef
54.
Leal MF, Lima EM, Silva PN, Assumpção PP, Calcagno DQ, Payão SL, et al. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil. World J Gastroenterol. 2007;13:2568–74.PubMed
55.
Guimarães AC, Lima EM, Khayat AS, Girão Faria MH, Barem Rabenhorst SH, Pitombeira MV, et al. Lima De Lima PD, De Arruda Cardoso Smith M, Burbano RR. Interrelationships among chromosome aneuploidy, promoter hypermethylation, and protein expression of the CDKN2A gene in individuals from northern Brazil with gastric adenocarcinoma. Cancer Genet Cytogenet. 2007;179:45–51.PubMedCrossRef
56.
Song SH, Jong HS, Choi HH, Kang SH, Ryu MH, Kim NK, et al. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma. Int J Cancer. 2000;87:236–40.PubMedCrossRef
57.
Fang JY, Yang L, Zhu HY, Chen YX, Lu J, Lu R, et al. 5-Aza-2′-deoxycitydine induces demethylation and up-regulates transcription of p16INK4A gene in human gastric cancer cell lines. Chin Med J. 2004;117:99–103.PubMed
58.
Liu J, Xie YS, Wang FL, Zhang LJ, Zhang Y, Luo HS. Cytotoxicity of 5-aza-2′-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16(INK4A). Biomed Pharmacother. 2013;67:78–87.PubMedCrossRef
59.
Mitsuno M, Kitajima Y, Ide T, Ohtaka K, Tanaka M, Satoh S, et al. Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients. J Gastroenterol. 2007;42:866–73.PubMedCrossRef
60.
Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev. 2000;9:849–53.PubMed
61.
Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, et al. MTHFR 677 T carrier influences the methylation status of H. pylori-infected gastric mucosa in older subjects. Dig Dis Sci. 2009;54:2391–8.PubMedCrossRef
Metadata
Title
Analysis of the methylation patterns of the p16 INK4A , p15 INK4B , and APC genes in gastric adenocarcinoma patients from a Brazilian population
Authors
Bárbara do Nascimento Borges
Rommel Mario Rodriguez Burbano
Maria Lúcia Harada
Publication date
01-08-2013
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2013
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0742-y

Other articles of this Issue 4/2013

Tumor Biology 4/2013 Go to the issue

Research Article

RETRACTED ARTICLE: CYP2D6 T188C variant is associated with lung cancer risk in the Chinese population

Review

Model of tumor-associated epigenetic changes of HER2, ER, and PgR expression in invasive breast cancer phenotypes

Review

Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding

Review

Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme

Review

Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions

Research Article

XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits